Cures Within Reach Utilizes Small Grants to Advance Drug Repurposing Efforts
Cures Within Reach, a Chicago-based nonprofit, is pioneering the use of small grants to support early-stage clinical trials for drug repurposing. This approach focuses on testing existing drugs for new therapeutic uses, which is faster and less costly than developing new drugs. Despite the potential benefits, large pharmaceutical companies often overlook these opportunities due to expired patents and limited commercial incentives. The nonprofit's model involves funding small proof-of-concept trials to generate initial data, which can then attract larger investments for further research. This strategy has been effective in bridging the 'valley of death'—the funding gap between promising lab results and human trials. Cures Within Reach has successfully leveraged its $12 million in grants to secure $145 million in follow-on investments, demonstrating the potential of small-scale funding to catalyze significant advancements in medical research. 
